BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 22097694)

  • 1. [Prognostic markers in chronic lymphocytic leukemia].
    Motycková M; Zák P; Vroblová V; Andrýs C; Belada D; Malý J; Smolej L
    Vnitr Lek; 2011 Oct; 57(10):847-57. PubMed ID: 22097694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis of chronic lymphocytic leukemia: focus on recent biomarkers].
    Véronèse L; Tchirkov A; Gouas L; Périssel B; Goumy C; Vago P
    Ann Biol Clin (Paris); 2008; 66(4):371-7. PubMed ID: 18725337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
    Montillo M; Hamblin T; Hallek M; Montserrat E; Morra E
    Haematologica; 2005 Mar; 90(3):391-9. PubMed ID: 15749671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
    Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
    Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
    van't Veer MB; Brooijmans AM; Langerak AW; Verhaaf B; Goudswaard CS; Graveland WJ; van Lom K; Valk PJ
    Haematologica; 2006 Jan; 91(1):56-63. PubMed ID: 16434371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and therapeutic implications of the mutational status of IgVH in patients with chronic lymphocytic leukemia.
    Kharfan-Dabaja MA; Chavez JC; Khorfan KA; Pinilla-Ibarz J
    Cancer; 2008 Sep; 113(5):897-906. PubMed ID: 18618518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
    Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of prognostic factors in patients with chronic B-lymphocytic leukemia at the time of diagnosis].
    Cmunt E; Michalová K; Sindelárová L; Karban J; Zemanová Z; Kurková S; Brezinová J; Schwarz J; Bosáková Z
    Sb Lek; 2002; 103(3):359-70. PubMed ID: 12688180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification in chronic lymphocytic leukemia.
    Seiler T; Döhner H; Stilgenbauer S
    Semin Oncol; 2006 Apr; 33(2):186-94. PubMed ID: 16616065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters?
    Molica S
    Haematologica; 1997; 82(6):705-9. PubMed ID: 9499672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.
    Maloum K; Settegrana C; Chapiro E; Cazin B; Leprêtre S; Delmer A; Leporrier M; Dreyfus B; Tournilhac O; Mahe B; Nguyen-Khac F; Lesty C; Davi F; Merle-Béral H
    Ann Hematol; 2009 Dec; 88(12):1215-21. PubMed ID: 19340428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic factors in chronic lymphocytic leukaemia: contribution of recent biological markers].
    Evrard S; Gaussem P; Helley D; Darnige L
    Ann Biol Clin (Paris); 2005; 63(6):589-97. PubMed ID: 16330377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and clinical staging in chronic lymphocytic leukemia.
    Rai KR; Han T
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):447-56. PubMed ID: 2182601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytogenetic markers in chronic lymphocytic leukemia].
    Nguyen-Khac F
    Ann Biol Clin (Paris); 2010; 68(3):273-6. PubMed ID: 20478769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukaemia.
    Boelens J; Lust S; Vanhoecke B; Offner F
    Anticancer Res; 2009 Feb; 29(2):605-15. PubMed ID: 19331210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binet's staging system and VH genes are independent but complementary prognostic indicators in chronic lymphocytic leukemia.
    Vasconcelos Y; Davi F; Levy V; Oppezzo P; Magnac C; Michel A; Yamamoto M; Pritsch O; Merle-Béral H; Maloum K; Ajchenbaum-Cymbalista F; Dighiero G
    J Clin Oncol; 2003 Nov; 21(21):3928-32. PubMed ID: 14581416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin gene rearrangements and in vitro growth of stromal cells are prognostic indexes in B-chronic lymphocytic leukemia.
    Tripputi P; Bignotto M; Cigognini D; Pellegrini C; Corneo G
    Ann Ital Med Int; 2004; 19(3):171-4. PubMed ID: 15529944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity.
    Mansouri M; Sevov M; Fahlgren E; Tobin G; Jondal M; Osorio L; Roos G; Olivecrona G; Rosenquist R
    Leuk Res; 2010 Mar; 34(3):301-6. PubMed ID: 19709746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL).
    Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A
    Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.